Summa Health System

General Catalyst formed HATCo specifically to own and operate a health system as a proving ground for its portfolio companies. Acquiring Summa outright gives HATCo direct governance over clinical and operational decisions, rather than relying on arms-length pilot agreements. The $515 million deal, which closed in January 2025, converted Summa from a nonprofit to a for-profit, allowing the venture firm to test and deploy technologies across Summa's Akron, Barberton, and Medina campuses with full organizational alignment (per the Wall Street Journal, January 2025).

Post-acquisition, Summa's investment posture is governed by HATCo's leadership under Marc Harrison, with board oversight that includes HATCo-appointed directors. The legacy Summa pension fund operates separately with its own fiduciary structure. Strategic capital allocation — particularly technology procurement and campus redevelopment — flows through HATCo's priorities rather than an independent health system investment committee. Since this is a corporate operating entity rather than a traditional allocator, there is no endowment or foundation vehicle making external fund commitments.

Yes, Summa Health retains a defined-benefit pension plan for legacy employees. Pension assets are managed by a fiduciary board separate from the operating entity's balance sheet and were explicitly ring-fenced during the HATCo acquisition, per regulatory filings with the Ohio Department of Insurance reviewed by Crain's Cleveland Business in 2024. The pension fund's investment committee and external managers are responsible for asset allocation decisions; HATCo does not direct pension investment strategy.

SummaCare, Summa Health's affiliated health insurance entity, was part of the assets included in the HATCo acquisition. The insurer covers commercial, Medicare Advantage, and Medicaid populations primarily in Ohio. Under HATCo, SummaCare can serve as a distribution channel for care models and technologies tested at Summa's clinical sites, creating a payer-provider feedback loop that is central to General Catalyst's health assurance thesis — though specific integration timelines have not been publicly detailed.

Summa's American Nurses Credentialing Center Magnet status, a designation recognizing nursing excellence, signals institutional investment in clinical workforce quality. Under HATCo, this designation may influence which technology pilots deploy on nursing units, as the staffing model and quality metrics provide a controlled environment for testing workforce-automation tools. Maintaining Magnet status also imposes operational standards that constrain cost-cutting approaches typical in for-profit conversions, a structural tension the new board must navigate.

No. Summa Health does not operate as a traditional institutional allocator making fund commitments. Instead, it functions as a venture-owned operating company where its clinical assets — hospitals, outpatient centers, and a health plan — serve as deployment sites for General Catalyst portfolio companies. The capital at work is General Catalyst's, deployed through HATCo, not a Summa-managed investment portfolio.

The conversion of a 501(c)(3) nonprofit health system to for-profit status in Ohio required review by the Ohio Attorney General's office and the Ohio Department of Insurance, given Summa's insurance subsidiary SummaCare. Community-benefit commitments were structured into the deal, though the details of those commitments have been the subject of local reporting in Akron by the Akron Beacon Journal through early 2025. The transaction also drew attention as a precedent for venture-capital ownership of a full health system.